Growth Metrics

Chs (CHSCP) EBITDA (2016 - 2026)

Chs (CHSCP) has disclosed EBITDA for 17 consecutive years, with -$241.8 million as the latest value for Q1 2026.

  • Quarterly EBITDA fell 40.61% to -$241.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Feb 2026, down 95.18% year-over-year, with the annual reading at $90.8 million for FY2025, 84.47% down from the prior year.
  • EBITDA hit -$241.8 million in Q1 2026 for Chs, down from $121.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $644.5 million in Q4 2022 to a low of -$241.8 million in Q1 2026.
  • Historically, EBITDA has averaged $159.5 million across 5 years, with a median of $137.8 million in 2024.
  • Biggest five-year swings in EBITDA: skyrocketed 476.91% in 2023 and later crashed 354.14% in 2025.
  • Year by year, EBITDA stood at $644.5 million in 2022, then plummeted by 39.04% to $392.9 million in 2023, then crashed by 64.92% to $137.8 million in 2024, then fell by 12.04% to $121.2 million in 2025, then tumbled by 299.44% to -$241.8 million in 2026.
  • Business Quant data shows EBITDA for CHSCP at -$241.8 million in Q1 2026, $121.2 million in Q4 2025, and $53.9 million in Q3 2025.